FDA Investigator Felicia E Armbrustmacher
Felicia E Armbrustmacher has conducted inspections on 9 sites in 1 countries as of 14 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
9
Last Inspection Date:
14 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Felicia E Armbrustmacher:
Anthony R Petriella,
Brian P Putz,
David J Gasparovich,
Deanna L Lampley,
Felicia E Hinojosa,
Geoffrey K Kilili,
Laureen F Kononen,
Laureen M Geniusz,
Martha Sullivan Myrick,
Matthew J Gretkierewicz,
Mishelle L Harriger,
Nancy A Bellamy,
Preston M Lee,
Sargum C Sood,
Suyang Qin,
Thomas A Peter,
Tracey L Siebesma,
Vesa Vuniqi,
William D Tingley
Felicia E Armbrustmacher's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2023 | FDA 483 | O3UV, LLC - Form 483, 2023-09-21 |
April, 2024 | FDA 483 | Excel Medical Products, Inc. - Form 483, 2024-04-01 |
January, 2024 | FDA 483 | Delphinus Medical Technologies, Inc. - Form 483, 2024-01-19 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more